Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report
ConclusionFurther studies into the biology of sequential immunotherapy in the treatment of cancer are warranted.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Genetics | Immunotherapy | Melanoma | Rhabdomyolysis | Skin Cancer | Study | Toxicology | Yervoy